Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 | ||
By: GlobeNewswire - 21 Feb 2024 | Back to overview list |
|
Management will also participate in two upcoming healthcare conferences SALT LAKE CITY, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its fourth quarter earnings conference call on Tuesday, February 27, 2024 at 4:30p.m. EST. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the fourth quarter and full year 2023. Revenue and earnings guidance for 2024 will also be shared. A live webcast of the earnings conference call can be accessed on Myriad’s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. Following the conference call, an archived webcast of the call will be available at investor.myriad.com. March Investor Conferences
A live and archived webcast of both presentations can be viewed in the investor relations section of Myriad’s website at investor.myriad.com. About Myriad Genetics Investor Contact Media Contact
|
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |